22 research outputs found

    Respiratory viral surveillance of healthcare personnel and patients at an adult long-term care facility

    Get PDF
    We conducted active surveillance of acute respiratory viral infections (ARIs) among residents and healthcare personnel (HCP) at a long-term care facility during the 2015-2016 respiratory illness season. ARIs were observed among both HCP and patients, highlighting the importance of including HCP in surveillance programs

    Comparison of fast-track diagnostics respiratory pathogens multiplex real-time RT-PCR assay with in-house singleplex assays for comprehensive detection of human respiratory viruses

    Get PDF
    Fast-track Diagnostics respiratory pathogens (FTDRP) multiplex real-time RT-PCR assay was compared with in-house singleplex real-time RT-PCR assays for detection of 16 common respiratory viruses. The FTDRP assay correctly identified 26 diverse respiratory virus strains, 35 of 41 (85%) external quality assessment samples spiked with cultured virus and 232 of 263 (88%) archived respiratory specimens that tested positive for respiratory viruses by in-house assays. Of 308 prospectively tested respiratory specimens selected from children hospitalized with acute respiratory illness, 270 (87.7%) and 265 (86%) were positive by FTDRP and in-house assays for one or more viruses, respectively, with combined test results showing good concordance (K=0.812, 95% CI = 0.786-0.838). Individual FTDRP assays for adenovirus, respiratory syncytial virus and rhinovirus showed the lowest comparative sensitivities with in-house assays, with most discrepancies occurring with specimens containing low virus loads and failed to detect some rhinovirus strains, even when abundant. The FTDRP enterovirus and human bocavirus assays appeared to be more sensitive than the in-house assays with some specimens. With the exceptions noted above, most FTDRP assays performed comparably with in-house assays for most viruses while offering enhanced throughput and easy integration by laboratories using conventional real-time PCR instrumentation. Published by Elsevier B.V.High Priority Pandemic and Seasonal Influenza Scientific proposal request initiativ

    CCL5 regulation of mucosal chlamydial immunity and infection

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Following genital chlamydial infection, an early T helper type 1 (Th1)-associated immune response precedes the activation and recruitment of specific Th1 cells bearing distinct chemokine receptors, subsequently leading to the clearance of <it>Chlamydia</it>. We have shown that CCR5, a receptor for CCL5, is crucial for protective chlamydial immunity. Our laboratory and others have also demonstrated that CCL5 deficiencies found in man and animals can increase the susceptibility and progression of infectious diseases by modulating mucosal immunity. These findings suggest the CCR5-CCL5 axis is necessary for optimal chlamydial immunity. We hypothesized CCL5 is required for protective humoral and cellular immunity against <it>Chlamydia</it>.</p> <p>Results</p> <p>The present study revealed that CCR5 and CCL5 mRNAs are elevated in the spleen, iliac lymph nodes (ILNs), and genital mucosa following <it>Chlamydia muriduram </it>challenge. Antibody (Ab)-mediated inhibition of CCL5 during genital chlamydial infection suppressed humoral and Th1 > Th2 cellular responses by splenic-, ILN-, and genital mucosa-derived lymphocytes. Antigen (Ag)-specific proliferative responses of CD4<sup>+ </sup>T cells from spleen, ILNs, and genital organs also declined after CCL5 inhibition.</p> <p>Conclusion</p> <p>The suppression of these responses correlated with delayed clearance of <it>C. muriduram</it>, which indicate chlamydial immunity is mediated by Th1 immune responses driven in part by CCL5. Taken together with other studies, the data show that CCL5 mediates the temporal recruitment and activation of leukocytes to mitigate chlamydial infection through enhancing adaptive mucosal humoral and cellular immunity.</p

    Preparation and characterization of Cu-Zro2 nanocomposite by DC method

    Get PDF
    Cu-ZrO2&nbsp;nanocomposite coatings prepared by electrodeposition method. In bath solution containing different amount of ZrO2&nbsp;were studied. The structure, surface morphology, mechanical and corrosion resistance properties of nanocomposite are characterized by varies techniques. Cu-ZrO2&nbsp;composite coatings have higher micro hardness, compared to pure copper coating. Surface morphology of both Cu and Cu–ZrO2&nbsp;composite coatings were examined through Scanning electron microscopy. The results show that more number of zirconia particles incorporated into copper matrix and then smooth surface, finer grain sized. The incorporation of ZrO2&nbsp;particles reduces the particle size. It shows the closer particle-particle contact leads to pore free deposition. The X-ray diffraction was conformed the crystallite size and structure of the electrodeposited Cu and Cu–ZrO2&nbsp;composite coatings. The average crystallite size calculated from Scherrer equation was ~105 nm for copper and ~67 nm for Cu-ZrO2&nbsp;composites. The structure of electrodeposited Cu and Cu–ZrO2&nbsp;composite coatings were crystalline orthorhombic which was confirmed from the JCPDS standard. The corrosion resistance behavior of Cu–ZrO2&nbsp;composite is examined through Tafel polarization and impedance measurement studies in 3.5% NaCl. The result shows that the Cu–ZrO2&nbsp;composite coatings have more corrosion resistance than pure Cu coating

    Severe Respiratory Illness Outbreak Associated with Human Coronavirus NL63 in a Long-Term Care Facility

    No full text
    We describe an outbreak of severe respiratory illness associated with human coronavirus NL63 in a long-term care facility in Louisiana in November 2017. Six of 20 case-patients were hospitalized with pneumonia, and 3 of 20 died. Clinicians should consider human coronavirus NL63 for patients in similar settings with respiratory disease

    Elevation of Alanine Aminotransferase Activity Occurs after Activation of the Cell-Death Signaling Initiated by Pattern-Recognition Receptors ‎but before Activation of Cytolytic Effectors in NK or CD8+ T Cells in the Liver During Acute HCV Infection

    No full text
    <div><p>Pattern-recognition receptors (PRRs) promote host defenses against HCV infection by binding to their corresponding adapter molecules leading to the initiation of innate immune responses including cell death. We investigated the expression of PRR genes, biomarkers of liver cell-death, and T cell and NK cell activation/inhibition-related genes in liver and serum obtained from three experimentally infected chimpanzees with acute HCV infection, and analyzed the correlation between gene expression levels and clinical profiles. Our results showed that expression of hepatic RIG-I, TLR3, TLR7, 2OAS1, and CXCL10 mRNAs was upregulated as early as 7 days post-inoculation and peaked 12 to 83 days post-inoculation. All of the three HCV infected chimpanzees exhibited significant elevations of serum alanine aminotransferase (ALT) activity between 70 and 95 days after inoculation. Elevated levels of serum cytokeratin 18 (CK-18) and caspases 3 and 7 activity coincided closely with the rise of ALT activity, and were preceded by significant increases in levels of caspase 3 and caspase 7 mRNAs in the liver. Particularly we found that significant positive auto-correlations were observed between RIG-I, TLR3, CXCL10, 2OAS1, and PD-L1 mRNA and ALT activity at 3 to 12 days before the peak of ALT activity. However, we observed substantial negative auto-correlations between T cell and NK cell activation/inhibition-related genes and ALT activity at 5 to 32 days after the peak of ALT activity. Our results indicated cell death signaling is preceded by early induction of RIG-I, TLR3, 2OAS1, and CXCL10 mRNAs which leads to elevation of ALT activity and this signaling pathway occurs before the activation of NK and T cells during acute HCV infection. Our study suggests that PRRs and type I IFN response may play a critical role in development of liver cell injury related to viral clearance during acute HCV infection.</p></div

    Lag correlation coefficients between ALT activity and other markers based on the Pearson correlation model.

    No full text
    <p>Lag correlation coefficients between ALT activity and other markers based on the Pearson correlation model.</p

    Smoothed trajectories of each hepatic mRNA expression compared to ALT activity during acute HCV infection.

    No full text
    <p>Hepatic expression of mRNAs was up-regulated before the peak (A), at the peak (B), and after the peak of ALT activity.</p

    Pearson correlation coefficients for association between HCV RNA, ALT activity and other markers in chimpanzees with acute HCV infection.

    No full text
    <p>Pearson correlation coefficients for association between HCV RNA, ALT activity and other markers in chimpanzees with acute HCV infection.</p
    corecore